Dr. Fliegelman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13755 Cicero Ave
Crestwood, IL 60418Phone+1 888-220-6432Fax+1 630-654-4253
Education & Training
Rush University Medical CenterFellowship, Infectious Disease, 1982 - 1984
Philadelphia College of Osteopathic MedicineClass of 1979
Certifications & Licensure
IL State License 1980 - 2026
NE State License 2019 - 2026
AZ State License 2019 - 2026
MI State License 2012 - 2025
WI State License 2019 - 2025
WA State License 2019 - 2025
TN State License 2019 - 2025- Join now to see all
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 16 citationsTocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise, Robert M. Fliegelman, Jonathan Pinsky
Clinical and Translational Science. 2021-11-01 - 10 citationsEarly Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2Russell M. Petrak, Nicholas W. Van Hise, Nathan C. Skorodin, Robert M. Fliegelman, Vishnu Chundi
Critical Care Explorations. 2021-03-29 - 27 citationsInfectious Diseases Specialty Intervention Is Associated With Better Outcomes Among Privately Insured Individuals Receiving Outpatient Parenteral Antimicrobial Therapy.Akshay Shah, Russell M. Petrak, Robert M. Fliegelman, Nabin K. Shrestha, Geneve M. Allison
Clinical Infectious Diseases. 2019-03-19
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
